Sponsors
Meet Our Event Sponsors
Our line-up of visionary companies ready to connect with you, offering leading technologies and solutions to advance your biomarker research.
![Sponsor Circle Image Sponsor Circle Image](https://oxfordglobal.com/hs-fs/hubfs/Sponsor%20Circle%20Image.png?width=400&height=400&name=Sponsor%20Circle%20Image.png)
Biomarkers US 2024
Gold Sponsors
Silver Sponsors
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/3a2f70e8-cb46-4d6c-834a-38c87ed9afff-2-5668375logo-Olink-Logotype_Black.png?length=600&name=3a2f70e8-cb46-4d6c-834a-38c87ed9afff-2-5668375logo-Olink-Logotype_Black.png)
Olink offers an unmatched high-multiplex technique to identify actionable biomarkers, with a strong focus on the human plasma proteome. Using minimal sample volume we provide quantifiable results with high-throughput, exceptional sensitivity and specificity, with coverage across a broad dynamic range. Our mission is to accelerate proteomics together with the scientific community across multiple disease areas to enable new discoveries and better understand complex real-time human biology. We are committed to develop our offering and are continuously expanding our protein coverage for a growing number of biological processes and pathways. Olink is well-established in Europe (HQ Uppsala, Sweden) and the USA (HQ Boston, MA), with a rapidly developing presence across Asia. We also work with a growing number of core labs around the world offering analysis and support to an expanding global customer base. For more information visit www.olink.com.
Bronze Sponsors
Network & Programme Sponsors
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Sponsor%20Logos/c457dfe2-407e-4638-9da4-e532c00f0373-2-5668375logo-300-300-logo.png?length=600&name=c457dfe2-407e-4638-9da4-e532c00f0373-2-5668375logo-300-300-logo.png)
Almac Diagnostic Services Always a move ahead in precision medicine Your global partner for biomarker discovery, development & commercialisation. Our global CLIA and CAP accredited laboratories cover UK, Europe, USA and APAC regions. Our core services: Genomic Services The flexibility of a range of genomics platform and chemistry options, alongside expert data sciences support & a full sample management service. Clinical Trial Assays Comprehensive CTA development, validation & delivery service for research and clinical use assays, alongside Global Clinical Trial Testing capabilities. Companion Diagnostics A collaborative end to end CDx development, manufacture & commercialisation service with the organisational and logistical resources necessary to launch tests in every major market. Make the winning move today www.almacgroup.com/diagnostics
Biomarkers Europe 2024
Platinum Sponsors
Gold Sponsors
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Sponsor%20Logos/d7ff43b7-3bb9-449d-ba0d-dd03a7d17cd7-2-5668375logo-Labcorp_Logo_Horizontal_Color_RGB.jpg?length=600&name=d7ff43b7-3bb9-449d-ba0d-dd03a7d17cd7-2-5668375logo-Labcorp_Logo_Horizontal_Color_RGB.jpg)
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 67,000 employees serve clients in approximately 100 countries, provided support for 84% of the new drugs and therapeutic products approved in 2023 by the FDA and performed more than 600 million tests for patients around the world. Learn more about us at www.labcorp.com.
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Sponsor%20Logos/12726510-a126-484d-9105-8b2b69791e96-2-5668375logo-Somalogic-SBI-Logo-Stacked_K_RGB_110520.png?length=600&name=12726510-a126-484d-9105-8b2b69791e96-2-5668375logo-Somalogic-SBI-Logo-Stacked_K_RGB_110520.png)
SomaLogic, a part of Standard BioTools, is catalyzing drug research and development and biomarker identification as a global leader in proteomics technology. With a single 55 microliter plasma or serum sample, SomaLogic can run 11,000 protein measurements, covering half the human proteome. For more than 20 years we’ve supported pharmaceutical companies, and academic and contract research organizations who rely on our protein detection and analysis technologies to fuel drug, disease, and treatment discoveries in such areas as oncology, diabetes, and cardiovascular, liver and metabolic diseases. Find out more at www.somalogic.com and follow @somalogic on LinkedIn.
Silver Sponsors
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/images%20(2).png?length=600&name=images%20(2).png)
At abcam, we believe the scientific community goes further, faster when we go there together. And to keep on making ground-breaking discoveries, we need to work together in new ways. That’s why we’re constantly innovating to help scientists drive their research forward by providing products and solutions that play an essential role in fundamental research, drug discovery, diagnostic and therapeutic applications. We started with a simple mission: to provide the best biological reagents to life scientists worldwide. Today, we help 750,000 researchers in over 130 countries deliver faster breakthroughs in areas like cancer, neurological disorders, infectious diseases, and metabolic disorders.
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Logos/Sponsor%20Logos/ARC%20Regulatory.png?length=600&name=ARC%20Regulatory.png)
ARC Regulatory is an NI-based specialist regulatory and clinical research organisation, dedicated to supporting companies in the in vitro diagnostic and precision medicine sector. The company’s mission is to be the preferred partner for the global precision medicine and IVD industry, supporting the development of kinder treatments and expediting the highest quality clinical research for improved patient outcomes. In delivering this mission, ARC is proud to have supported more than 50 global biomarker-driven drug programmes with the world’s top targeted therapy R&D leaders.
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Logos/Sponsor%20Logos/CellCarta.png?length=600&name=CellCarta.png)
Leading provider of specialized precision medicine laboratory services with integrated platforms in immunology, histopathology, proteomics, genomics, and related specimen collection and logistics services. CellCarta supports the entire drug development cycle, from discovery to late-stage clinical trials, and operates globally with laboratories in Canada, USA, Belgium, Australia, and China.
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Logos/Sponsor%20Logos/Discovery%20Life%20Sciences%20LLC.png?length=600&name=Discovery%20Life%20Sciences%20LLC.png)
Discovery Life Sciences accelerates the discovery and development of new therapies and diagnostics by providing biopharma and diagnostic companies with the highest quality biospecimens, in vitro preclinical products, and cell & gene therapy starting materials coupled with specialty lab services that are grounded in science and offered at scale to support large scale clinical trials.
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/3a2f70e8-cb46-4d6c-834a-38c87ed9afff-2-5668375logo-Olink-Logotype_Black.png?length=600&name=3a2f70e8-cb46-4d6c-834a-38c87ed9afff-2-5668375logo-Olink-Logotype_Black.png)
Olink offers an unmatched high-multiplex technique to identify actionable biomarkers, with a strong focus on the human plasma proteome. Using minimal sample volume we provide quantifiable results with high-throughput, exceptional sensitivity and specificity, with coverage across a broad dynamic range. Our mission is to accelerate proteomics together with the scientific community across multiple disease areas to enable new discoveries and better understand complex real-time human biology. We are committed to develop our offering and are continuously expanding our protein coverage for a growing number of biological processes and pathways. Olink is well-established in Europe (HQ Uppsala, Sweden) and the USA (HQ Boston, MA), with a rapidly developing presence across Asia. We also work with a growing number of core labs around the world offering analysis and support to an expanding global customer base. For more information visit www.olink.com
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/acb74fe3-b6e2-492e-b1d5-b9a1da2a09f6-2-5668375logo-PFM-Logo.jpg?length=600&name=acb74fe3-b6e2-492e-b1d5-b9a1da2a09f6-2-5668375logo-PFM-Logo.jpg)
When Precision for Medicine’s name was chosen back in 2012, it signalled our commitment to a new movement shaping medical R&D, the movement to bring precision to the development of novel treatments. More than just a CRO, under one global roof, we’ve brought precision for medicine by integrating biomarker capabilities, worldwide CRO services, in-country regulatory expertise, specialty and central labs, technical manufacturing solutions and more. Precision is solving the intricate challenges our clients face when developing new therapeutics and together, we are propelling medicine forward.
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Logos/Sponsor%20Logos/Sapient%20Bioanalytics%20.png?length=600&name=Sapient%20Bioanalytics%20.png)
Sapient is a biomarker discovery organization providing bespoke services for metabolomics, lipidomics, and proteomics data generation and analysis, enabling biopharma sponsors to go beyond the genome to accelerate precision drug development. Using state-of-the-art, high-throughput mass spectrometry technologies, Sapient enables nontargeted multi-omics measurements to capture thousands of dynamic biomarkers in human, preclinical, and cellular biosamples, across thousands of samples at a time. These technologies are leveraged within a larger discovery infrastructure that includes a comprehensive biocomputational framework for analysis of large-scale, multi-omics data;robust quality control analysis;and mapping of key biomarker-phenotype associations. Sapient can cross-validate discoveries using our proprietary in-house longitudinal Human Biology Database that includes data from over 100,000 human biosamples with paired phenotypic measures. Together our approaches enable rapid identification, validation, and translation of dynamic biomarkers of biological processes, disease mechanisms, and drug response across all drug development phases.
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Sponsor%20Logos/67328ae2-05de-4a79-bb8b-25b02298ae68-2-5668375logo-Seer-CMYK-Fullcolor.png?length=600&name=67328ae2-05de-4a79-bb8b-25b02298ae68-2-5668375logo-Seer-CMYK-Fullcolor.png)
Seer develops innovative solutions that act as a gateway to the proteome. Our products are designed to accelerate the pace of proteomics by removing the technological barriers that stand between you and the proteomics you want to do. The Proteograph platform enables unbiased, deep, rapid, large-scale proteomics studies – the kind needed to advance our understanding of biology, health, and disease. It is now possible to accurately survey and analyze the full diversity of proteins across individuals, over time. Our goal is to empower the scientific community with tools for exceptional proteomics outcomes.
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Logos/Sponsor%20Logos/sengenics.png?length=600&name=sengenics.png)
Sengenics, a functional proteomics company, is committed to advancing precision medicine by empowering researchers with biologically relevant and actionable immunoproteomic insights across a broad spectrum of diseases. At the heart of its mission, Sengenics offers advanced, high-throughput tools using proprietary technology to precisely detect autoantibody biomarkers and protein interactions for basic, translational, and clinical research. Its robust tools have been leveraged by top pharmaceutical companies and leading research institutions to enhance disease understanding and streamline the biomarker pipeline. Sengenics is headquartered in the U.S. and has a worldwide network of offices, distributors, and service providers.
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/84427842-faee-4395-8be2-cf6017bd6e2f-2-5668375logo-logo_Ultivue_tag_black.png?length=600&name=84427842-faee-4395-8be2-cf6017bd6e2f-2-5668375logo-logo_Ultivue_tag_black.png)
Ultivue provides researchers with the clearest profile of cancer biology, enabling them to see more, see faster, and see in situ. Through clinical-grade InSituPlex® assays and advanced AI-driven STARVUE™ spatial image analysis pipeline, Ultivue empowers scientists developing precision cancer therapies to gain quantitative, high-confidence insights in just a fraction of the time.
Bronze Sponsors
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Sponsor%20Logos/cellecta-logo%202024.png?length=600&name=cellecta-logo%202024.png)
Cellecta Inc. is a trusted provider of genomic products and services for drug target and biomarker discovery. Since 2006, we have collaborated with the world’s leading pharma, biotech, government, and academic institutions. We apply our extensive expertise in viral vector production, functional screening, custom cell engineering and multiplex qRT-PCR to help researchers find the genes that matter.
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Sponsor%20Logos/d7563f0d-f009-49cd-8a2d-f682a079a3bb-2-5668375logo-ICON-Positive-logo-JPEG(nostrap).jpg?length=600&name=d7563f0d-f009-49cd-8a2d-f682a079a3bb-2-5668375logo-ICON-Positive-logo-JPEG(nostrap).jpg)
ICON is the world’s leading clinical research organisation, powered by healthcare intelligence. From molecule to medicine, we advance clinical research providing outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in Dublin, Ireland, ICON employs approximately 41,150 employees in 113 locations in 53 countries. For further information, visit www.iconplc.com
Network & Programme Sponsors
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Sponsor%20Logos/Almac_Logo_Original_No%20Strapline.png?length=600&name=Almac_Logo_Original_No%20Strapline.png)
Almac Diagnostic Services support global pharma and biotech companies with their biomarker strategies from biomarker discovery through to companion diagnostic partnerships. Almac has clinical and research laboratories in Europe and the USA, alongside strategic partnerships in China, enabling us to support global studies. The services offered fall into three main categories:
• Genomic Services (Range of Platforms & Technologies, Sample Management, Data Sciences) • Clinical Trial Assays (Research Use Assays, Clinical Use Assays, Global Clinical Trial Testing) • Companion Diagnostics (CDx Development, CDx Manufacture, CDx Commercialisation)
https://www.almacgroup.com/diagnostics/
• Genomic Services (Range of Platforms & Technologies, Sample Management, Data Sciences) • Clinical Trial Assays (Research Use Assays, Clinical Use Assays, Global Clinical Trial Testing) • Companion Diagnostics (CDx Development, CDx Manufacture, CDx Commercialisation)
https://www.almacgroup.com/diagnostics/
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Sponsor%20Logos/13766f1e-3684-4fcc-a560-4688278783a5-2-5668375logo-BioIVTLogo_CMYK_Tag.png?length=600&name=13766f1e-3684-4fcc-a560-4688278783a5-2-5668375logo-BioIVTLogo_CMYK_Tag.png)
BioIVT enables smarter science and accelerates medical breakthroughs by delivering high-quality personalized biospecimen solutions and research services to life science and diagnostic industries. Recognized as an industry leader, we specialize in control and disease state samples including human and animal tissues or preparations, cell and gene therapy products, blood, and other biofluids, as well as ADME contract research services from standalone bioanalytical support through tiered in vitro studies with submission-ready reports to customized consulting. By combining our technical expertise, exceptional customer service, and unmatched access to biological specimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE®.
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Sponsor%20Logos/522077e1-ef51-4851-a605-fe75bdfa8083-2-5668375logo-Concept-Life-Sciences-Master-Brand-RGB-Copy.jpg?length=600&name=522077e1-ef51-4851-a605-fe75bdfa8083-2-5668375logo-Concept-Life-Sciences-Master-Brand-RGB-Copy.jpg)
Concept Life Sciences, a collaborative client-centred approach. We are a multi-disciplined Contract Research Organisation based in the UK providing market-leading scientific services globally. Over the past 25 years, Concept Life Sciences and its heritage companies have played a pivotal role in guiding numerous clients along their path to clinical success and many of these clients have evolved into enduring scientific collaborators. Within a decade, the collaborative efforts of experts from our heritage businesses — Peakdale Molecular, CXR Biosciences, and Aquila Biomedical — have propelled us beyond the cumulative impact of our individual components, fostering substantial growth and advancement. We are based across 4 research sites in the UK delivering discovery research, as well as GMP, GLP, and GCP-regulated work. Whether it is delivering whole programs of research, or bespoke studies, we deliever a a collaborative client-centred approach. Our services include discovery chemistry, specialist translational biology for immunology, oncology and neuroscience, biologics, biophysical assays services, ADMET & DMPK, bioanalysis, toxicology, histology, analytical services, including materials characterisation and physiochemical analysis, process research and development, and GMP manufacturing.
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Website/Logos/Sponsor%20Logos/Kymos%20Group.png?length=600&name=Kymos%20Group.png)
Kymos is a GLP-certified and GCP-compliant multinational CRO inspected by the EMA and FDA. Our team of experts provides biomarker analysis, supporting you across all phases, from drug discovery to clinical sample analysis reaching multiple therapeutic areas. Equipped with state-of-the-art technologies and techniques such as Meso Scale Discovery (MSD®), Luminex®, qPCR, and LC-MS/MS, we offer a comprehensive catalog of biomarkers. This combination of expertise and technologies allows us to adapt and customize the biomarker determination according to each Clinical or Preclinical study’s specific needs. We are proficient in developing new methods from scratch, and depending on the study scope we can perform fit-to-purpose qualification or validation. Our team is experienced in pharmacodynamic studies to determine drug efficacy and safety (End-point determination), performing biomarker exploratory determinations, and screening of inflammatory markers as inclusion criteria for clinical studies.
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/7a44d6f2-e3f0-473a-8b2f-e2c2fe38c5f8-2-5668375logo-logo_MSD-circles.jpg?length=600&name=7a44d6f2-e3f0-473a-8b2f-e2c2fe38c5f8-2-5668375logo-logo_MSD-circles.jpg)
Meso Scale Discovery (MSD®) is a leader in high performance, multiplex-enabled biomarker assays for cytokines, toxicology, neurodegeneration and metabolic disease research, used by leading biopharmaceutical and academic researchers in human and animal model studies. MSD’s proprietary electrochemiluminescence (ECL) platform delivers exceptional sensitivity, wide dynamic range and rapid turnaround.
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/Sponsor%20Logos/a458cdfe-f040-48e8-95d1-fb2f1b8f8704-2-5668375logo-PersonalisCorporateLogo.png?length=600&name=a458cdfe-f040-48e8-95d1-fb2f1b8f8704-2-5668375logo-PersonalisCorporateLogo.png)
At Personalis, we are transforming the active management of cancer through breakthrough personalized testing. We aim to drive a new paradigm for cancer management, guiding care from biopsy through the life of the patient. Our highly sensitive assays combine tumor-and-normal profiling with proprietary algorithms to deliver advanced insights even as cancer evolves over time. Our products are designed to detect MRD and recurrence at the earliest timepoints, enable selection of targeted therapies based on ultra-comprehensive genomic profiling, and enhance biomarker strategy for drug development.
![](https://8696823.fs1.hubspotusercontent-na1.net/hub/8696823/hubfs/form-uploads/1e9fd071-dee6-44f7-8a8d-f7937e9d3970/017b7331-5329-49b0-8504-2a8369c6ab7c-2-5668375logo-Rules_Based_Medicine_Logo_JPG.jpg?length=600&name=017b7331-5329-49b0-8504-2a8369c6ab7c-2-5668375logo-Rules_Based_Medicine_Logo_JPG.jpg)
Rules-Based Medicine (RBM), a Q2 Solutions Company, is the world’s leading multiplexed immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services and a novel whole blood immunophenotyping device (TruCulture®). RBM’s internally developed and manufactured immunoassays based on Multi-Analyte Profiling (MAP) and Single-Molecule Array (SimoaTM) ultrasensitive immunoassay technology provides translational and clinical researchers with reproducible and quantitative data for a few or hundreds of human proteins. The comprehensive menu provides extensive coverage of numerous pathways and delivers accurate pharmacodynamic and safety assessments. RBM’s CLIA certified biomarker testing laboratory is located in Austin, TX. Q2 Solutions is a leading global clinical trial laboratory services organization providing bioanalytical, genomics, vaccines, flow cytometry, anatomic pathology, immunoassay, companion diagnostics and central laboratory services with secure, enterprise-wide biospecimen and consent management solutions. With our industry-leading science, partnership approach and innovative solutions, we’ll make sure our clients get the results that will turn patients’ hope into the help they need.
Our extensive and engaged community extends across large, mid-size and innovative start-ups within the pharma and biotech space, with a dedicated audience spanning a range of specialisms. Whether you have content to share, are looking for ways to enhance your brand visibility or would like to increase engagement with prospective customers, Oxford Global can offer valuable access to your target demographic through our range of event & content services.
-
At Oxford Global, our events are designed to connect key life science figures and innovative solution providers, accelerating scientific advancement. Our goal is to create valuable connections and an impactful experience through innovative and collaborative formats.
-
Digital Marketing Services
Oxford Global’s products offer a powerful channel to associate your brand with the latest advancements within the industry whilst educating and influencing the industry throughout their buying process.